Guardion Health Sciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Operating Revenue	11.89	11.91	10.64	6.95	1.89	0.88
Other Revenue	0.34	0.34	0.41	0.28	0	0.02
Revenue	12.23	12.25	11.05	7.23	1.89	0.9
Revenue Growth (YoY)	119.79%	10.85%	52.77%	282.74%	109.30%	-4.16%
Cost of Revenue	6.78	6.85	6.53	4.12	1.95	0.34
Gross Profit	5.45	5.39	4.52	3.11	-0.06	0.56
Selling, General & Admin	8.88	9.19	11.65	13.53	8.9	9.3
Research & Development	0.15	0.15	0.19	0.06	0.16	0.19
Operating Expenses	9.02	9.34	11.84	13.59	9.06	9.5
Operating Income	-3.58	-3.94	-7.32	-10.48	-9.12	-8.93
Interest Expense	-	-	-	-	-0.01	-0.26
Interest & Investment Income	0.38	0.38	0.15	0	-	-
Other Non Operating Income (Expenses)	-1.8	3.98	2.35	0	-0.01	-0.12
EBT Excluding Unusual Items	-4.99	0.42	-4.82	-10.48	-9.14	-9.31
Merger & Restructuring Charges	-	-	-	-2.1	-	-
Impairment of Goodwill	-	-	-	-11.89	-	-1.56
Gain (Loss) on Sale of Assets	-0.28	-0.26	-0.01	-0.16	-0.05	-
Asset Writedown	-	-	-10.09	-	-	-
Other Unusual Items	-	-	-	-0.11	0.62	-
Pretax Income	-5.28	0.16	-14.92	-24.75	-8.57	-10.88
Net Income	6.37	0.16	-14.92	-24.75	-8.57	-10.88
Preferred Dividends & Other Adjustments	-	-	0.94	-	-	-
Net Income to Common	6.37	0.16	-15.86	-24.75	-8.57	-10.88
Shares Outstanding (Basic)	1	1	1	0	0	0
Shares Outstanding (Diluted)	1	1	1	0	0	0
Shares Change (YoY)	2.26%	13.37%	136.61%	66.16%	134.56%	80.64%
EPS (Basic)	4.99	0.12	-14.15	-52.23	-30.06	-89.49
EPS (Diluted)	4.99	0.12	-14.15	-52.23	-30.06	-89.49
Free Cash Flow	-3.92	-4.37	-7.45	-10.72	-8.05	-6.2
Free Cash Flow Per Share	-3.07	-3.44	-6.65	-22.62	-28.25	-51.01
Gross Margin	44.56%	44.04%	40.91%	43.00%	-3.00%	62.20%
Operating Margin	-29.24%	-32.18%	-66.26%	-144.94%	-482.49%	-989.37%
Profit Margin	52.13%	1.29%	-143.57%	-342.11%	-453.56%	-1204.77%
Free Cash Flow Margin	-32.05%	-35.71%	-67.44%	-148.19%	-426.21%	-686.77%
EBITDA	-3.56	-3.92	-6.07	-9.7	-9.05	-8.46
EBITDA Margin	-29.08%	-32.02%	-54.95%	-134.11%	-	-
D&A For EBITDA	0.02	0.02	1.25	0.78	0.07	0.48
EBIT	-3.58	-3.94	-7.32	-10.48	-9.12	-8.93
EBIT Margin	-29.24%	-32.18%	-66.26%	-144.94%	-	-
Revenue as Reported	12.25	12.25	11.05	7.23	1.89	0.9
Advertising Expenses	-	1.45	1.62	0.16	0.04	0.02

Source: S&P Global Market Intelligence. Standard template. Financial Sources.